FDA Drug Application (204505) for LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE by AUROBINDO PHARMA LTD

Back to FDA Applications sponsored by AUROBINDO PHARMA LTD

Application Number204505
Product Number001
FormTABLET; ORAL
Dosage300MG; 300MG; 200MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE
Active IngredientLAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE

Active IngredientCount
List of drugs with Active Ingredient LAMIVUDINE39
List of drugs with Active Ingredient NEVIRAPINE17
List of drugs with Active Ingredient TENOFOVIR DISOPROXIL FUMARATE15


Back to FDA Applications sponsored by AUROBINDO PHARMA LTD